Home › Products › Others › Aplevant 1.5mg Injection

Aplevant 1.5mg Injection

Salt Composition: DULAGLUTIDE

₹5386.00₹5669.00

Inclusive of all taxes

Categories: Others

Conditions: Diabetes Mellitus

Product Introduction

Aplevant 1.5mg Injection contains Dulaglutide, a GLP-1 RA used to manage type 2 diabetes by improving glycemic control when diet and exercise alone are not sufficient. It is often prescribed with medications such as metformin or sulfonylureas and helps reduce the risk of hyperglycemia and hypoglycemia. Aplevant Injection may also support weight loss and weight management. The Aplevant dosage should be followed as prescribed, and it is available as an Aplevant 1.5mg pre-filled pen. Any use of Aplevant 1.5mg substitutes should be guided by a healthcare professional, and patients often compare Aplevant vs Trulicity when considering GLP-1 RA treatment options.

Uses

Aplevant 1.5mg uses are: Treatment of type 2 diabetes Weight management

How it works

Aplevant 1.5mg Injection, a GLP-1 receptor agonist, improves glycemic control in individuals with type 2 diabetes by stimulating insulin secretion, suppressing glucagon release (a hormone that prevents excessive glucose production by the liver.), and slowing gastric emptying. These actions work together to lower blood sugar levels, promote weight loss or weight maintenance, and reduce appetite. By addressing multiple aspects of diabetes management, this medication offers a comprehensive therapeutic effect for individuals with type 2 diabetes.

Side Effects

aplevant 1.5 mg injection side effects are Serious: Pancreatitis (inflammation of the pancreas) Thyroid C-cell tumor (type of thyroid cancer) Common: Nausea Vomiting Diarrhea Abdominal pain

Expert Tips

Inform your healthcare provider about any known allergies or previous adverse reactions before receiving Aplevant 1.5mg Injection. Be aware of potential side effects and seek immediate medical attention if they occur. Monitor renal function if you have moderate to severe kidney impairment, and take care when using this medication with insulin secretagogues or insulin to avoid hypoglycemia. If you have a history of cardiac arrhythmias or unstable cardiovascular disease, close monitoring may be necessary due to possible increased heart rate. Follow proper injection technique and rotate injection sites to reduce the risk of injection site reactions. If you are pregnant or breastfeeding, discuss the potential risks and benefits with your healthcare professional. Communicate openly with your doctor and promptly report any unusual symptoms or concerns while taking this medication.

References

  1. Eli Lilly and Company Limited, Electronic medicines compendium (EMC), [Revised on 25th May 2023], [Accessed on 31st May 2023], https://www.medicines.org.uk/emc/files/pil.3634.pdf
  2. Eli Lilly and Company, US Food and Drug Administration, [Revised on January 2017] [Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125469s007s008lbl.pdf
  3. KD Tripathi, Essentials of Medical Pharmacology, 2018, 8th Edition, 1002

Safety Advice

Pregnancy: unsafe The safety of Aplevant 1.5mg Injection use during pregnancy has not been established. If you are pregnant or planning to become pregnant, discussing the potential risks and benefits with your healthcare professional is essential.

Lungs: Consult your doctor Suppose you have a pre-existing lung condition or are concerned about the safety of the Aplevant 1.5mg Injection in your lungs. In that case, consulting with your healthcare provider for personalized advice is recommended.

Breastfeeding: Consult your doctor Women should consult a doctor while breastfeeding while taking the Aplevant 1.5mg Injection.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS